response to the inhaled bronchodilator , metaproterenol , was evaluated in 28 outpatient infants and young children with cystic fibrosis ( cf ) ( mean age , 16 months ) and in 22 normal control children ( mean age , 13 months ) .
C0021270
infants
C0008059
children